Robert H. Vonderheide - Publications, H-index & Citations

Robert H. Vonderheide

University of Pennsylvania

99H指数

774论文数

4.4W被引数

收录论文 151

发表时间

Developing neoantigen cancer vaccines: where are we now?开发新抗原癌症疫苗：我们目前进展如何？

Nature Communications

IF15.7

2026-09-10

OAAI

Nune Markosyan; Robert H. Vonderheide

A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection 模块化 γ δ tcr-t平台，将KRAS pMHC靶向与可重复剂量的mRNA接合器重定向相结合

Journal of Hematology & Oncology

IF40.4

2026-07-30

OAAI

Ángel Ramírez-Fernández; Adham S. Bear; Elahe Kamali; Robert Bartoszek; Matthew Ho; Gregory M. Chen; Devin Dersh; Laura Córdoba-Espejo; Jiageng Liu; Mosha Deng; Miriam Velasco-Sidro; Ankita Jain; Julia Han Noll; Caitlin R Hopkins; Owen Koucky; Janna Minehart; Alexander J. Dimitri; Erik Williams; Maya Lavorando; Alejandro Segura-Tudela; John Scholler; Julie Barber-Rotenberg; Julie K. Jadlowsky; Daniel J. Powell; Anne Chew; Vanessa E. Gonzalez; Donald L. Siegel; Bruce L. Levine; Michael T. Lotze; Carl H. June; James L. Riley; Robert H. Vonderheide; Friederike Herbst; Joseph A. Fraietta

An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses 一种Il12 mRNA-LNP佐剂增强了mRNA疫苗诱导的CD8 T细胞反应

Science Immunology

IF16.3

2025-06-06

PREAI

Emily A. Aunins; Anthony T. Phan; Mohamad-Gabriel Alameh; Garima Dwivedi; Elisa Cruz-Morales; David A. Christian; Ying Tam; Molly E. Bunkofske; Anabel Zabala Peñafiel; Keenan M. O’Dea; Maria Merolle; Colleen Furey; Phillip Scott; Robert H. Vonderheide; Scott E. Hensley; Ross M. Kedl; Drew Weissman; Christopher A. Hunter

Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity

JCI INSIGHT

IF6.1

2024-11-08

OAAI

Markosyan, Nune; Kim, Il-Kyu; Arora, Charu; Quinones-Ware, Liz; Joshi, Nikhil; Cheng, Noah; Schechter, Emma Y.; Tobias, John W.; Hochberg, Joseph E.; Corse, Emily; Liu, Kang; Diblasi, Varenka Rodriguez; Chan, Li-Chuan (Eric); Smyth, Emer M.; Fitzgerald, Garret A.; Stanger, Ben Z.; Vonderheide, Robert H.

Addressing financial toxicity in cancer clinical trials: Acceptability and feasibility of a text-based intervention for the offering, screening, and enrolling of patients in a financial reimbursement program

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-21

PREAI

Santaniello, Ashley; Ramos, Elizabeth; Patel, Hena; Nguyen, Vivian; Dornsife, Dana; Johnson, Robert G.; Milinski, Sarah; Wileyto, E. Paul; Vonderheide, Robert H.; Guerra, Carmen E.

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2024-09-17

OAAI

Bear, Adham S.; Nadler, Rebecca B.; O'Hara, Mark H.; Stanton, Kelsey L.; Xu, Chong; Saporito, Robert J.; Rech, Andrew J.; Baroja, Miren L.; Blanchard, Tatiana; Elliott, Maxwell H.; Ford, Michael J.; Jones, Richard; Patel, Shivang; Brennan, Andrea; O'Neil, Zachary; Powell Jr, Daniel J.; Vonderheide, Robert H.; Linette, Gerald P.; Carreno, Beatriz M.

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

NATURE COMMUNICATIONS

IF15.7

2024-07-09

OAAI

Till, Jacob E.; McDaniel, Lee; Chang, Changgee; Long, Qi; Pfeiffer, Shannon M.; Lyman, Jaclyn P.; Padron, Lacey J.; Maurer, Deena M.; Yu, Jia Xin; Spencer, Christine N.; Gherardini, Pier Federico; Da Silva, Diane M.; LaVallee, Theresa M.; Abbott, Charles; Chen, Richard O.; Boyle, Sean M.; Bhagwat, Neha; Cannas, Samuele; Sagreiya, Hersh; Li, Wenrui; Yee, Stephanie S.; Abdalla, Aseel; Wang, Zhuoyang; Yin, Melinda; Ballinger, Dominique; Wissel, Paul; Eads, Jennifer; Karasic, Thomas; Schneider, Charles; O'Dwyer, Peter; Teitelbaum, Ursina; Reiss, Kim A.; Rahma, Osama E.; Fisher, George A.; Ko, Andrew H.; Wainberg, Zev A.; Wolff, Robert A.; O'Reilly, Eileen M.; O'Hara, Mark H.; Cabanski, Christopher R.; Vonderheide, Robert H.; Carpenter, Erica L.

Advancing Cancer Interception 推进癌症拦截

CANCER DISCOVERY

IF33.3

2024-04-04

OAAI

Domchek, Susan M.; Vonderheide, Robert H.

Resistance to RAS-GTP inhibition in models of pancreatic ductal adenocarcinoma arises downstream of RAS effectors

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Wasko, Urszula N.; Jiang, Jingjing; Wang, Yingyun; Tomassoni, Lorenzo; Jiang, Lingyan; Menard, Marie; Curiel-Garcia, Alvaro; Dalton, Tanner C.; Orlen, Margo; Edwards, Cole; Stalnecker, Clint; Dilly, Julien; Chang, Stephanie; Sastra, Stephen A.; Palermo, Carmine F.; Baslan, Timour; Tian, Sha; Holderfield, Matthew; Quintana, Elsa; Wang, Zhengping; Smith, Jacqueline A.; Califano, Andrea; Wildes, David; Aguirre, Andrew J.; Vonderheide, Robert H.; Stanger, Ben Z.; Lowe, Scott W.; Der, Channing J.; Singh, Mallika; Olive, Kenneth P.

Addressing financial toxicity in cancer clinical trial participation: Barriers and facilitators of enrolling in a reimbursement program for out-of-pocket travel costs

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Ramos, Elizabeth; Nguyen, Vivian; Santaniello, Ashley; Dornsife, Dana; Johnson, Robert G.; Wileyto, Paul E.; Vonderheide, Robert H.; Guerra, Carmen E.

CD40 agonism induces CD4 T cell mediated rejection of major histocompatibility complex class I deficient pancreatic tumors

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Haerr, Margaret E.; Kim, Samuel I.; Arora, Charu; Gribbin, Kyle P.; Vonderheide, Robert H.; Byrne, Katelyn T.

Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing anti-tumor immunity

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Markosyan, Nune; Kim, Ilkyu; Arora, Charu; Cheng, Noah; Schechter, Emma; Tobias, John; Stanger, Ben; Vonderheide, Robert

Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma

NATURE COMMUNICATIONS

IF15.7

2024-02-20

OAAI

Kim, Il-Kyu; Diamond, Mark S.; Yuan, Salina; Kemp, Samantha B.; Kahn, Benjamin M.; Li, Qinglan; Lin, Jeffrey H.; Li, Jinyang; Norgard, Robert J.; Thomas, Stacy K.; Merolle, Maria; Katsuda, Takeshi; Tobias, John W.; Baslan, Timour; Politi, Katerina; Vonderheide, Robert H.; Stanger, Ben Z.

Tumor-selective inhibition of active RAS in pancreatic ductal adenocarcinoma

CANCER RESEARCH

IF16.6

2024-01-16

PREAI

Wasko, Urszula N.; Jiang, Jingjing; Tomassoni, Lorenzo; Wang, Yingyun; Lee, Bianca; Orlen, Margo; Drizyte-Miller, Kristina; Menard, Marie; Dilly, Julien; Sastra, Steven A.; Palermo, Carmine F.; Chang, Stephanie; Aguirre, Andrew J.; Der, Channing J.; Vonderheide, Robert H.; Stanger, Ben Z.; Califano, Andrea; Singh, Mallika; Olive, Kenneth P.

Tumor cell-intrinsic mPGES-1-PGE2-EP4 signaling is a major immunosuppressive pathway in pancreatic cancer

CANCER RESEARCH

IF16.6

2024-01-16

PREAI

Markosyan, Nune; Kim, Il-Kyu; Arora, Charu; Quinones, Liz; Cheng, Noah; Stanger, Ben Z.; Vonderheide, Robert H.

Quantitative MRI metrics capture pancreatic cancer and stroma responses to novel KRAS inhibitor

CANCER RESEARCH

IF16.6

2024-01-16

PREAI

Gupta, Mamta; Choi, Hoon; Furth, Emma E.; Joaquim, Miguel; Pickup, Stephen; Clendenin, Cynthia; Orlen, Margo; Karasic, Thomas; Song, Hee Kwon; Fan, Yong; O'Dwyer, Peter; Vonderheide, Robert H.; Rosen, Mark; Stanger, Ben Z.; Zhou, Rong

Immune vulnerabilities of mutant KRAS in pancreatic cancer

TRENDS IN CANCER

IF17.5

2023-11-01

OAAI

Cheng, Noah C.; Vonderheide, Robert H.

Ferroptosis of immune cells in the tumor microenvironment 肿瘤微环境中免疫细胞的铁死亡

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2023-08-01

OAAI

Kim, Rina; Taylor, Devon; Vonderheide, Robert H.; Gabrilovich, Dmitry I.

Cancer vaccines are back, revitalized

MED

IF11.8

2023-07-01

PREAI

Vonderheide, Robert H.

An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences

BMC GENOMICS

IF3.7

2023-06-26

OAAI

Gurun, Burcu; Horton, Wesley; Murugan, Dhaarini; Zhu, Biqing; Leyshock, Patrick; Kumar, Sushil; Byrne, Katelyn T.; Vonderheide, Robert H.; Margolin, Adam A.; Mori, Motomi; Spellman, Paul T.; Coussens, Lisa M.; Speed, Terence P.

研究方向